Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Entecavir
- Therapeutic area
- Anti-infectives
- Drug class
- Antivirals
- ATC
- J05
- Strength
- 0.05 mg/mL
- Dosage form
- Oral solution
- Pack
- 120ml
- Registration no.
- 091488
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-14 03:07
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Neuclud (Entecavir) is used for
Entecavir is an antiviral medicine for long-lasting (chronic) hepatitis B, a virus that attacks the liver. It belongs to a group called nucleoside analogues. It stops the virus from copying itself in the liver, so the amount of virus in the body goes down and the liver can get healthier. It controls the virus but usually does not cure it. WHO recommends entecavir as one of two main medicines for chronic hepatitis B, because it works well, has few side effects and the virus rarely becomes resistant to it. Treatment is started and checked by a hospital liver (hepatology) specialist team, and most people need it for a long time, often for life.
- Chronic hepatitis B infection in adults, including people whose liver is still working well and people whose liver is badly damaged and not working properly
- Chronic hepatitis B in children and teenagers aged 2 years and older whose liver is still working well, under specialist care
- Lowering the amount of hepatitis B virus in the blood so that liver damage slows down or improves
Get medical help straight away if
- Get emergency help for signs of a severe allergic reaction, such as swelling of the face, lips, tongue or throat, or difficulty breathing.
- Contact a doctor straight away for signs of lactic acidosis (a rare but serious build-up of acid in the blood): feeling or being sick with stomach pain, difficulty breathing, unusual muscle pain, extreme weakness or tiredness, dizziness, or a fast or uneven heartbeat.
- Contact a doctor straight away for signs of liver problems: yellow skin or eyes, dark urine, or pain or swelling in the stomach area.
- If treatment is stopped, hepatitis can suddenly get worse. Tell your liver team at once if you feel unwell, or notice yellow skin or eyes, after stopping.
Side effects, warnings and interactions for Entecavir
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Entecavir
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Entecavir is right for you and the dose.
- Hepatitis B: first choice for chronic hepatitis B
About Neuclud 0.05 mg/mL oral solution
Neuclud 0.05 mg/mL oral solution contains Entecavir 0.05 mg/mL. It is registered with DRAP by Neutro Pharma (Pvt.) Ltd (registration no. 091488). Its official price is PKR 5,186.21 for a pack of 120ml. This price has applied since 27 July 2026. It is sold in 2 pack sizes: 120ml and 210ml. Neuclud is also available as 0.5 mg tablet and 1 mg tablet. 5 other brands of Entecavir 0.05 mg/mL (oral solution) are registered in Pakistan. Compare all brands and prices →
Neuclud 0.05 mg/mL pack sizes and prices
| Pack | Official price | Per tablet |
|---|---|---|
| 120ml (this page) | PKR 5,186.21 | — |
| 210ml | PKR 9,075.87 | — |
Other strengths of Neuclud
All 5 other brands of Entecavir 0.05 mg/mL solution in Pakistan
These 5 brands are alternatives (substitutes) to Neuclud: each contains Entecavir 0.05 mg/mL solution. Ask your doctor or pharmacist before you switch brands.
Sorted by price per mL, lowest first. The lowest is Atrivir (M/s. Genix Pharma (Pvt) Ltd) at PKR 40.01 per mL; the highest is BELIC at PKR 43.22. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Atrivir | M/s. Genix Pharma (Pvt) Ltd | 120ml | PKR 4,801.11 | PKR 40.01 / mL |
| GENOVIREX | Atco Laboratories Limited | 120ml | PKR 4,801.12 | PKR 40.01 / mL |
| ENTAV | Hilton Pharma (Pvt) Limited | 120ml | PKR 5,054.39 | PKR 42.12 / mL |
| Radavir | Radiant Pharma (Pvt.) Ltd | 120ml | PKR 5,186.21 | PKR 43.22 / mL |
| BELIC | SAMI Pharmaceuticals Pvt. Ltd | 120ml | PKR 5,186.31 | PKR 43.22 / mL |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Neuclud, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Neutro Pharma (Pvt.) Ltd.,, Lahore
- DRAP registration
- 091488
- Phone
- +92 42 37339087-89
- info@neutropharma.com
- Website
- https://neutropharma.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (120ml). Current price PKR 5,186.21, effective 27 Jul 2026.
Cite this price history
MedInfoBase. Neuclud 0.05 mg/mL, 120ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/neuclud-0-05-mg-ml-091488-120ml-neutro-pharma-pvt-ltd-7249/ (accessed 14 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 5,186.21 | 2026-07-27 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 091488Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.